Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Drop in Short Interest

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) was the recipient of a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 97,700 shares, a decline of 9.4% from the August 31st total of 107,800 shares. Based on an average daily volume of 2,070,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.6% of the shares of the stock are short sold.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Bluejay Diagnostics stock. CVI Holdings LLC bought a new stake in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 66,165 shares of the company’s stock, valued at approximately $46,000. CVI Holdings LLC owned about 19.69% of Bluejay Diagnostics at the end of the most recent quarter. 18.47% of the stock is currently owned by institutional investors.

Bluejay Diagnostics Price Performance

NASDAQ:BJDX traded down $0.00 on Monday, reaching $0.14. The stock had a trading volume of 451,640 shares, compared to its average volume of 748,342. Bluejay Diagnostics has a 12-month low of $0.13 and a 12-month high of $38.96. The company has a market cap of $45,494.40, a price-to-earnings ratio of 0.00 and a beta of 0.73. The firm’s fifty day moving average is $0.29 and its two-hundred day moving average is $2.64.

Bluejay Diagnostics (NASDAQ:BJDX) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($5.12) earnings per share (EPS) for the quarter.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.